Can riboflavin offer a novel personalised strategy for maintaining healthy blood pressure in pregnancy in populations globally?
- 2025-09-08
- Review
- BMJ nutrition, prevention & health 8(2)
- Bethany Duffy
- Anmol Patted
- Rupsa C Boelig
- Mary Murphy
- Kristina Pentieva
- Mary Ward
- Diane Lees-Murdock
- Victor Garcia
- Frank Barry
- Vanessa Short
- Catherine Hughes
- Richard Derman
- Helene McNulty
- PubMed: 41768514
- DOI: 10.1136/bmjnph-2025-001212
- Low evidence
randomised trials show that supplemental riboflavin can effectively lower blood pressure specifically in individuals with the variant MTHFR 677TT genotype, independently of antihypertensive medications.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes